The study on the epidemiology of psychological, alimentary health and nutrition (SEPAHAN): Overview of methodology

Journal of Research in Medical Sciences

Volumn 17, Issue SUPPL.2, 2012, Pages

  Adibi, Peyman ^a   Keshteli, Ammar Hassanzadeh ^a   Esmaillzadeh, Ahmad ^b   Afshar, Hamid ^c   Roohafza, Hamidreza ^c   Bagherian Sararoudi, Reza ^d   Daghaghzadeh, Hamed ^a   Soltanian, Nouroddin ^a   Feinle Bisset, Christine ^e   Boyce, Philip ^f   Talley, Nicholas J ^g,h  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e UNIVERSITY OF ADELAIDE   (Australia)

^f UNIVERSITY OF SYDNEY   (Australia)

^g MAYO CLINIC   (United States)

^h UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Anxiety; Depression; Functional gastrointestinal disorders; Iran; Nutrition; Personality trait

Indexed keywords

ANXIETY; COPING BEHAVIOR; CROSS-SECTIONAL STUDY; DIETARY INTAKE; DIGESTIVE SYSTEM FUNCTION DISORDER; DISTRESS SYNDROME; EATING HABIT; HUMAN; LIFE EVENT; LIFESTYLE; MAJOR CLINICAL STUDY; MENTAL HEALTH; NUTRITION; PERSONALITY; PREVALENCE; QUESTIONNAIRE; REVIEW; SOCIAL SUPPORT;

EID: 84865211890     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Rasquin A, Di LC, Forbes D, Guiraldes E, Hyams JS, Staiano A, et al. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology 2006; 130(5): 1527-37.
2. Fukudo S, Kuwano H, Miwa H. Management and pathophysiology of functional gastrointestinal disorders. Digestion 2012; 85(2): 85-9.
3. Choi MG, Jung HK. Health related quality of life in functional gastrointestinal disorders in Asia. J Neurogastroenterol Motil 2011; 17(3): 245-51.
4. Halder SL, Locke GR, III, Schleck CD, Zinsmeister AR, Melton LJ, III, Talley NJ. Natural history of functional gastrointestinal disorders: a 12-year longitudinal populationbased study. Gastroenterology 2007; 133(3): 799-807.
5. Chang JY, Locke GR, III, McNally MA, Halder SL, Schleck CD, Zinsmeister AR, et al. Impact of functional gastrointestinal disorders on survival in the community. Am J Gastroenterol 2010; 105(4): 822-32.
6. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006; 130(5): 1377-90.
7. Drossman DA. The functional gastrointestinal disorders and the Rome II process. Gut 1999; 45(2): 1-80.
8. Pilichiewicz AN, Horowitz M, Holtmann GJ, Talley NJ, FeinleBisset C. Relationship between symptoms and dietary patterns in patients with functional dyspepsia. Clin Gastroenterol Hepatol 2009; 7(3): 317-22.
9. Pilichiewicz AN, Feltrin KL, Horowitz M, Holtmann G, Wishart JM, Jones KL, et al. Functional dyspepsia is associated with a greater symptomatic response to fat but not carbohydrate, increased fasting and postprandial CCK, and diminished PYY. Am J Gastroenterol 2008; 103(10): 2613-23.
10. Heizer WD, Southern S, McGovern S. The role of diet in symptoms of irritable bowel syndrome in adults: a narrative review. J Am Diet Assoc 2009; 109(7): 1204-14.
11. Ho W, Spiegel BM. The relationship between obesity and functional gastrointestinal disorders: causation, association, or neither? Gastroenterol Hepatol (N Y) 2008; 4(8): 572-8.
12. Feinle-Bisset C, Vozzo R, Horowitz M, Talley NJ. Diet, food intake, and disturbed physiology in the pathogenesis of symptoms in functional dyspepsia. Am J Gastroenterol 2004; 99(1): 170-81.
13. Levy RL, Olden KW, Naliboff BD, Bradley LA, Francisconi C, Drossman DA, et al. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology 2006; 130(5): 1447-58.
14. Wu JC. Psychological Co-morbidity in Functional Gastrointestinal Disorders: Epidemiology, Mechanisms and Management. J Neurogastroenterol Motil 2012; 18(1): 13-8.
15. Olafsdottir LB, Gudjonsson H, Jonsdottir HH, Bjornsson E, Thjodleifsson B. Natural history of functional gastrointestinal disorders: comparison of two longitudinal population-based studies. Dig Liver Dis 2012; 44(3): 211-7.
16. Koloski NA, Talley NJ, Boyce PM. Epidemiology and health care seeking in the functional GI disorders: a population-based study. Am J Gastroenterol 2002; 97(9): 2290-9.
17. Cremonini F, Talley NJ. Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors. Gastroenterol Clin North Am 2005; 34(2): 189-204.
18. Khoshkrood-Mansoori B, Pourhoseingholi MA, Safaee A, Moghimi-Dehkordi B, Sedigh-Tonekaboni B, Pourhoseingholi A, et al. Irritable bowel syndrome: a population based study. J Gastrointestin Liver Dis 2009; 18(4): 413-8.
19. Khademolhosseini F, Mehrabani D, Nejabat M, Beheshti M, Heydari ST, Mirahmadizadeh A, et al. Irritable bowel syndrome in adults over 35 years in Shiraz, southern Iran: prevalence and associated factors. J Res Med Sci 2011; 16(2): 200-6.
20. Ganji A, Malekzadeh F, Safavi M, Nassri-Moghaddam S, Nourie M, Merat S, et al. Digestive and liver disease statistics in Iran. Middle East J Dig Dis 2011; 1(2): 56-62.
21. Adibi P, Behzad E, Pirzadeh S, Mohseni M. Bowel habit reference values and abnormalities in young Iranian healthy adults. Dig Dis Sci 2007; 52(8): 1810-3.
22. Adibi P, Mazdak H, Derakhshandeh A, Toghiani A. Change in functional bowel symptoms after prostatectomy: a case-control study. J Res Med Sci 2011; 16(2): 130-5.
23. Jahangiri P, Jazi MS, Keshteli AH, Sadeghpour S, Amini E, Adibi P. Irritable bowel syndrome in Iran: SEPAHAN systematic review No. 1. Int J Prev Med 2012; 3(Suppl1): S1-S9.
24. Amini E, Keshteli AH, Hashemi Jazi MS, Jahangiri P, Adibi P. Dyspepsia in Iran: SEPAHAN systematic review No. 3. Int J Prev Med 2012; 3(Suppl1): S18-S25.
25. Daneshpajouhnejad P, Keshteli AH, Sadeghpour S, Ardestani SK, Adibi P. Bloating in Iran: SEPAHAN systematic review No. 4. Int J Prev Med 2012; 3(Suppl1): S26-33.
26. Iraji N, Keshteli AH, Sadeghpour S, Daneshpajouhnejad P, Fazel M, Adibi P. Constipation in Iran: SEPAHAN systematic review No. 5. Int J Prev Med 2012; 3(Suppl1): S34-41.
27. Talley NJ, Locke GR, III, Herrick LM, Silvernail VM, Prather CM, Lacy BE, et al. Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics. Contemp Clin Trials 2012; 33(3): 523-33.
28. Ghoshal UC, Singh R, Chang FY, Hou X, Wong BC, Kachintorn U. Epidemiology of uninvestigated and functional dyspepsia in Asia: facts and fiction. J Neurogastroenterol Motil 2011; 17(3): 235-44.
29. Barzkar M, Pourhoseingholi MA, Habibi M, MoghimiDehkordi B, Safaee A, Pourhoseingholi A, et al. Uninvestigated dyspepsia and its related factors in an Iranian community. Saudi Med J 2009; 30(3): 397-402.
30. Khademolhosseini F, Mehrabani D, Zare N, Salehi M, Heydari ST, Bheshti M, et al. Prevalence of dyspepsia and its correlation with demographic factors and lifestyle in Shiraz, southern Iran. Middle East J Dig Dis 2010; 2(1): 24-30.
31. Sadeghpour S, Keshteli AH, Daneshpajouhnejad P, Jahangiri P, Adibi P. Ramadan fasting and digestive disorders: SEPAHAN systematic review No. 7. J Res Med Sci 2012; 17(Suppl1): S150-S158.
32. World Health Organization. Process of translation and adaptation of instruments. [Online]. 2012. [cited 2012 Mar 11]; Available from: URL: http://www.who.int/substance_abuse/research_tools/translation/en/. Accessed: March 11, 2012.
33. National Health Service. The General Practice Physical Activity Questionnaire (GPPAQ).2006.
34. Esmaillzadeh A, Barak F, Adibi P, Azadbakht L, Keshteli AH, Fallahi E, et al. Adherence to DASH diet in relation to obesity among Iranian female nurses. [MSc Thesis]. Isfahan: Nutrition, Food Security Research Center, Isfahan Unioversity of Medical Sciences; 2010.
35. Osterberg T, Tsuga K, Rothenberg E, Carlsson GE, Steen B. Masticatory ability in 80-year-old subjects and its relation to intake of energy, nutrients and food items. Gerodontology 2002; 19(2): 95-101.
36. Talley NJ, Phillips SF, Wiltgen CM, Zinsmeister AR, Melton LJ, III. Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc 1990; 65(11): 1456-79.
37. Attanasio V, Andrasik F, Blanchard EB, Arena JG. Psychometric properties of the SUNYA revision of the Psychosomatic Symptom Checklist. J Behav Med 1984; 7(2): 247-57.
38. Montazeri A, Harirchi AM, Shariati M, Garmaroudi G, Ebadi M, Fateh A. The 12-item General Health Questionnaire (GHQ-12): translation and validation study of the Iranian version. Health Qual Life Outcomes 2003; 1: 66.
39. Montazeri A, Vahdaninia M, Ebrahimi M, Jarvandi S. The Hospital Anxiety and Depression Scale (HADS): translation and validation study of the Iranian version. Health Qual Life Outcomes 2003; 1: 14.
40. Zimet GD, Dahlem NW, Zimet SG, Farley GK. The multidimensional scale of perceived social support. J Pers Assess 1988; 52(1): 30-41.
41. Sararoudi RB, Afshar H, Adibi P, Daghaghzadeh H, Fallah J, Abotalebian F. Type D personality and quality of life in patients with irritable bowel syndrome. J Res Med Sci 2011; 16(8): 985-92.
42. Roohafza H, Ramezani M, Sadeghi M, Shahnam M, Zolfagari B, Sarafzadegan N. Development and validation of the stressful life event questionnaire. Int J Public Health 2011; 56(4): 441-8.
43. Carver CS, Scheier MF, Weintraub JK. Assessing coping strategies: a theoretically based approach. J Pers Soc Psychol 1989; 56(2): 267-83.
44. Costa PT, Jr., McCrae RR. Stability and change in personality assessment: the revised NEO Personality Inventory in the year 2000. J Pers Assess 1997; 68(1): 86-94.